Related Experiment Video
Updated: Aug 14, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Agnogenic myeloid metaplasia with pulmonary hematopoiesis
Anna Boula1, Elpis Mantadakis, Irini Xilouri
1University Hospital of Heraklion, Department of Hematology, Heraklion, Crete, Greece.
Abstract:
Agnogenic myeloid metaplasia (AMM) is characterized by bone marrow fibrosis, splenomegaly and leukoerythroblastic anemia and is frequently accompanied by extramedullary hematopoiesis (EMH). Pulmonary interstitial EMH associated with myelofibrosis has rarely been described in the medical literature and is usually fatal. We report the case of a 77-year-old man with agnogenic myeloid metaplasia (AMM) treated with hydroxyurea, who seven years after diagnosis presented with dyspnea and severe hypoxemia. Radionuclide bone marrow scanning demonstrated increased tracer activity on the bases of both lungs, consistent with non-hepatosplenic EMH. Pulmonary EMH is rare in patients with AMM, but should be considered in patients with hypoxemia and respiratory distress.
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Production of Formed Elements
Most HSCs commit to...
Lineage Commitment
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Hematopoiesis
Differentiation of Common Myeloid Progenitor Cells

